Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC3020390832;90833;90834 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
N2AB2856285909;85910;85911 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
N2A2763583128;83129;83130 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
N2B2113863637;63638;63639 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
Novex-12126364012;64013;64014 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
Novex-22133064213;64214;64215 chr2:178552293;178552292;178552291chr2:179417020;179417019;179417018
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACT
  • RefSeq wild type template codon: TGA
  • Domain: Ig-148
  • Domain position: 72
  • Structural Position: 155
  • Q(SASA): 0.2201
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/S None None 0.716 N 0.451 0.108 0.173771789658 gnomAD-2.1.1 3.19E-05 None None None None N None 0 0 None 0 0 None 0 None 0 6.48E-05 0
T/S None None 0.716 N 0.451 0.108 0.173771789658 gnomAD-4.0.0 4.791E-06 None None None None N None 0 0 None 0 0 None 0 0 6.29723E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.1291 likely_benign 0.135 benign -1.31 Destabilizing 0.016 N 0.335 neutral N 0.468230643 None None N
T/C 0.4347 ambiguous 0.464 ambiguous -0.753 Destabilizing 0.994 D 0.739 prob.delet. None None None None N
T/D 0.5577 ambiguous 0.5864 pathogenic -1.539 Destabilizing 0.979 D 0.727 prob.delet. None None None None N
T/E 0.4215 ambiguous 0.4293 ambiguous -1.295 Destabilizing 0.959 D 0.673 neutral None None None None N
T/F 0.4099 ambiguous 0.4161 ambiguous -0.899 Destabilizing 0.979 D 0.789 deleterious None None None None N
T/G 0.397 ambiguous 0.4203 ambiguous -1.726 Destabilizing 0.769 D 0.595 neutral None None None None N
T/H 0.3578 ambiguous 0.3862 ambiguous -1.684 Destabilizing 0.998 D 0.771 deleterious None None None None N
T/I 0.2299 likely_benign 0.2243 benign -0.194 Destabilizing 0.946 D 0.729 prob.delet. N 0.466242407 None None N
T/K 0.4022 ambiguous 0.4188 ambiguous -0.275 Destabilizing 0.959 D 0.667 neutral None None None None N
T/L 0.1505 likely_benign 0.1656 benign -0.194 Destabilizing 0.769 D 0.5 neutral None None None None N
T/M 0.1056 likely_benign 0.1126 benign -0.426 Destabilizing 0.994 D 0.741 deleterious None None None None N
T/N 0.1713 likely_benign 0.1887 benign -1.027 Destabilizing 0.973 D 0.672 neutral N 0.484386341 None None N
T/P 0.8375 likely_pathogenic 0.8384 pathogenic -0.539 Destabilizing 0.973 D 0.747 deleterious N 0.507517026 None None N
T/Q 0.3234 likely_benign 0.3474 ambiguous -0.718 Destabilizing 0.979 D 0.765 deleterious None None None None N
T/R 0.3292 likely_benign 0.3602 ambiguous -0.621 Destabilizing 0.959 D 0.737 prob.delet. None None None None N
T/S 0.1387 likely_benign 0.1519 benign -1.253 Destabilizing 0.716 D 0.451 neutral N 0.490150476 None None N
T/V 0.1753 likely_benign 0.1757 benign -0.539 Destabilizing 0.769 D 0.432 neutral None None None None N
T/W 0.7547 likely_pathogenic 0.767 pathogenic -1.073 Destabilizing 0.998 D 0.755 deleterious None None None None N
T/Y 0.3699 ambiguous 0.3838 ambiguous -0.666 Destabilizing 0.993 D 0.787 deleterious None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.